Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Subsequent Event for Jan. 10Q

Subsequent Event for Jan. 10Q

posted on Dec 18, 2007 09:33AM
Don't know if it has been mentioned, but these settlements will be deemed subsequent events for the quarter ended Nov. 30, so there may be some discussion included in the 10Q we'll get next month. I would not expect much disclosure based on Turley's note today, but perhaps we'll get more than we have now. Just a hopeful thought!
Share
New Message
Please login to post a reply